Systemic response to pneumonia in the critically ill patient

Seminars in Respiratory Infections

Volumn 18, Issue 2, 2003, Pages 68-71

  Multz, Alan S ^a   Cohen, Rubin ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CRITICAL ILLNESS; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; INFECTION RISK; LUNG ALVEOLUS CELL; PNEUMONIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BRONCHOALVEOLAR LAVAGE FLUID; CRITICAL ILLNESS; CYTOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-8; MALE; PNEUMONIA, BACTERIAL; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038795214     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lipscomb MF, Onofrio JM, Nash EJ, et al: A morphologic study of the role of phagocytes in the clearance of Staphylococcus aureus from the lung. J Reticuloend Soc 33:429-442, 1983
2. MacNee W, Selby C: Neutrophil kinetics in the lungs. Clin Sci 79:97-107, 1990
3. Toews GB, Gross GN, Pierce AK: The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Am Rev Respir Dis 120:559-566, 1979
4. Klebanoff SJ, Vadas MA, Harlan JM, et al: Stimulation of neutrophil by tumor necrosis factor. J Immunol 136:4220-4225, 1986
5. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989
6. Ming WJ, Bersani L, Mantovani A: Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 138:1469-1474, 1987
7. Michie HR, Manogue KR, Spriggs DR, et al: Defection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486, 1988
8. Michie HR, Spriggs DR, Manogue KR, et al: Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 194:280-286, 1988
9. Salyer JL, Bohnsack JF, Knape WA, et al: Mechanisms of tumor necrosis factor-α alteration of PMN adhesion and migration. Am J Pathol 136:831-841, 1990
10. Nelson S, Bagby GJ, Summer W: Anti-tumor necrosis factor-alpha antibody suppresses pulmonary anti-bacterial defenses. Am Rev Respir Dis 143S:393, 1991
11. Haslett C, Worthen GS, Ciclas PC, et al: The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbit. Am Rev Respir Dis 136:9-18, 1987
12. Worthen GS, Haslett C, Rees AJ, et al: Neutrophil-mediated pulmonary vascular injury: Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis 136:19, 1987
13. Lilly CM, Sandhu JS, Ishizaka A, et al: Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 139:1361-1368, 1989
14. Waterer GW, Quansey MW, Cantor RM, et al: Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respit Crit Care Med 163:1599-1604, 2001
15. Wundernick RG, Waterer GW, Cantor RM, et al: Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. Chest 121:878, 2002 (suppl 3)
16. Ulich R, Yin S, Guo K, et al: The intratracheal administration of endotoxin and cytokines: The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation. Am J Pathol 138:521-524, 1991
17. Luger A, Graf H, Schwarz HP, et al: Decreased serum interleukin-1 activity and monocyte interleukin-1 production in patients with fatal sepsis. Crit Care Med 14:458-461, 1986
18. Simpson SQ, Modi HN, Balk RA, et al: Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med 19:1060-1066, 1991
19. Jaffe HA, Buhl R, Masrangeli A, et al: Organ specific cytokine therapy. J Clin Invest 88:297-302, 1991
20. Nelson S, Nakamura C, Shellito J, et al: Intratracheal gamma-interferon enhances pulmonary host defenses against Pseudomonas aeruginosa. Am Rev Respir Dis 145S:337, 1992
21. Boutten A, Dehoux MS, Seta N, et al: Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 153:336-342, 1996
22. van der Poll T, Marchant A, Keogh CV, et al: Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174:994-1000, 1996
23. Brunda MJ: Interleukin-12. J Leukoc Biol 55:280, 1994
24. Muehlstedt SG, Richardson CJ, West MA, et al: Cytokines and the pathogenesis of nosocomial pneumonia. Surgery 130:602-609, 2001
25. Kanazawa M, Ishizaka A, Hasegawa N, et al: Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 145:1030-1035, 1992
26. Koizumi T, Kubo KJ, Shinozaki S, et al: Granulocyte colony-stimulating factor does not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis 148:132-137, 1993
27. Nelson S, Bagby GJ: Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis. Clin Chest Med 17:319-332, 1996
28. Yasuda H, Ajiki Y, Shimozato T, et al: Therapeutic efficacy if granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infection in mice. Infect Immun 58:2502-2509, 1990
29. Wunderink RG, Leeper KV, Schein R, et al: Filgrastim in patients with pneumonia and severe sepsis or septic shock. Chest 119:523-529, 2001
30. Maskin B, Fontan PA, Spinedi EG, et al: Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with gram-negative nosocomial pneumonia. Crit Care Med 30:349-354, 2002
31. Kawamae K, Pristine G, Chiumello D, et al: Partial liquid ventilation decreases serum tumor necrosis factor-α concentrations in a rat acid aspiration lung injury model. Crit Care Med 28:479-483, 2000
32. Buja LM, Eigenbrodt M, Eigenbrodt E: Apoptosis and necrosis: Basic types and mechanisms of cell death. Arch Pathol Lab Med 117:1208-1214, 1993
33. Majno G, Joris I: Apoptosis, oncosis and necrosis: An overview of cell death. Am J Pathol 146:3-15, 1995
34. Ware CF, VanArdsdale S, VanArdsdale TL: Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem 60:47-55, 1996
35. Stefanec T: Endothelial apoptosis. Chest 117:841-854, 2000
36. Behnia M, Robertson KA, Martin WJ: Lung infections: Role of apoptosis in host defense and pathogenesis of disease. Chest 117:1771-1777, 2000
37. Droemann D, Aries SP, Hansen F, et al: Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia. Chest 117:169-184, 2000